2-232336618-A-G

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_152383.5(DIS3L2):​c.2646A>G​(p.Ser882Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.103 in 1,603,266 control chromosomes in the GnomAD database, including 13,081 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. S882S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.13 ( 1713 hom., cov: 32)
Exomes 𝑓: 0.10 ( 11368 hom. )

Consequence

DIS3L2
NM_152383.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.256

Publications

15 publications found
Variant links:
Genes affected
DIS3L2 (HGNC:28648): (DIS3 like 3'-5' exoribonuclease 2) The protein encoded by this gene is similar in sequence to 3'/5' exonucleolytic subunits of the RNA exosome. The exosome is a large multimeric ribonucleotide complex responsible for degrading various RNA substrates. Several transcript variants, some protein-coding and some not, have been found for this gene. [provided by RefSeq, Mar 2012]
DIS3L2 Gene-Disease associations (from GenCC):
  • Perlman syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.027).
BP6
Variant 2-232336618-A-G is Benign according to our data. Variant chr2-232336618-A-G is described in ClinVar as [Benign]. Clinvar id is 262631.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.256 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.442 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DIS3L2NM_152383.5 linkc.2646A>G p.Ser882Ser synonymous_variant Exon 21 of 21 ENST00000325385.12 NP_689596.4 Q8IYB7-1
DIS3L2NR_046476.2 linkn.2719A>G non_coding_transcript_exon_variant Exon 21 of 21
DIS3L2NR_046477.2 linkn.3292A>G non_coding_transcript_exon_variant Exon 19 of 19
DIS3L2NM_001257281.2 linkc.1582-6727A>G intron_variant Intron 13 of 13 NP_001244210.1 Q8IYB7-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DIS3L2ENST00000325385.12 linkc.2646A>G p.Ser882Ser synonymous_variant Exon 21 of 21 5 NM_152383.5 ENSP00000315569.7 Q8IYB7-1

Frequencies

GnomAD3 genomes
AF:
0.126
AC:
19115
AN:
151878
Hom.:
1700
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.152
Gnomad AMI
AF:
0.0669
Gnomad AMR
AF:
0.182
Gnomad ASJ
AF:
0.0842
Gnomad EAS
AF:
0.457
Gnomad SAS
AF:
0.0801
Gnomad FIN
AF:
0.0801
Gnomad MID
AF:
0.0949
Gnomad NFE
AF:
0.0849
Gnomad OTH
AF:
0.144
GnomAD2 exomes
AF:
0.143
AC:
32887
AN:
230524
AF XY:
0.132
show subpopulations
Gnomad AFR exome
AF:
0.155
Gnomad AMR exome
AF:
0.257
Gnomad ASJ exome
AF:
0.0835
Gnomad EAS exome
AF:
0.455
Gnomad FIN exome
AF:
0.0846
Gnomad NFE exome
AF:
0.0873
Gnomad OTH exome
AF:
0.132
GnomAD4 exome
AF:
0.101
AC:
146236
AN:
1451268
Hom.:
11368
Cov.:
32
AF XY:
0.0995
AC XY:
71861
AN XY:
721996
show subpopulations
African (AFR)
AF:
0.151
AC:
5032
AN:
33406
American (AMR)
AF:
0.248
AC:
10947
AN:
44128
Ashkenazi Jewish (ASJ)
AF:
0.0871
AC:
2270
AN:
26064
East Asian (EAS)
AF:
0.481
AC:
19004
AN:
39510
South Asian (SAS)
AF:
0.0778
AC:
6656
AN:
85514
European-Finnish (FIN)
AF:
0.0896
AC:
4150
AN:
46310
Middle Eastern (MID)
AF:
0.113
AC:
639
AN:
5660
European-Non Finnish (NFE)
AF:
0.0815
AC:
90536
AN:
1110558
Other (OTH)
AF:
0.116
AC:
7002
AN:
60118
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
8216
16432
24647
32863
41079
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3506
7012
10518
14024
17530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.126
AC:
19152
AN:
151998
Hom.:
1713
Cov.:
32
AF XY:
0.127
AC XY:
9437
AN XY:
74294
show subpopulations
African (AFR)
AF:
0.153
AC:
6329
AN:
41454
American (AMR)
AF:
0.183
AC:
2792
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.0842
AC:
292
AN:
3468
East Asian (EAS)
AF:
0.458
AC:
2345
AN:
5124
South Asian (SAS)
AF:
0.0789
AC:
380
AN:
4814
European-Finnish (FIN)
AF:
0.0801
AC:
848
AN:
10592
Middle Eastern (MID)
AF:
0.109
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
0.0849
AC:
5769
AN:
67954
Other (OTH)
AF:
0.144
AC:
304
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
766
1532
2298
3064
3830
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
206
412
618
824
1030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0955
Hom.:
1210
Bravo
AF:
0.140
Asia WGS
AF:
0.222
AC:
771
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Perlman syndrome Benign:3
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 06, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.66
CADD
Benign
2.0
DANN
Benign
0.52
PhyloP100
-0.26
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3811578; hg19: chr2-233201328; COSMIC: COSV56053495; COSMIC: COSV56053495; API